{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:04:16Z","timestamp":1780099456633,"version":"3.54.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10151-018-1896-9","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T14:37:08Z","timestamp":1544452628000},"page":"941-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy"],"prefix":"10.1007","volume":"22","author":[{"given":"Giuseppe","family":"Leoncini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Villanacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Crisafulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moris","family":"Cadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Leoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrio","family":"Bassotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"1896_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ncpgasthep0031","volume":"1","author":"SB Hanauer","year":"2004","unstructured":"Hanauer SB (2004) Update on the etiology, pathogenesis and diagnosis of ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 1:26\u201331","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1896_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.crohns.2014.05.003","volume":"8","author":"V Villanacci","year":"2014","unstructured":"Villanacci V, Antonelli E, Reboldi G, Salemme M, Casella G, Bassotti G (2014) Endoscopic biopsy samples of na\u00efve \u201ccolitides\u201d patients: role of basal plasmacytosis. J Crohns Colitis 8:1438\u20131443","journal-title":"J Crohns Colitis"},{"key":"1896_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/apm.12639","volume":"125","author":"G Canavese","year":"2017","unstructured":"Canavese G, Villanacci V, Antonelli E, Cadei M, Sapino A, Rocca R, Daperno M, Suriani R, Di Santo MG, Cassoni P, Bernardini N, Bassotti G (2017) Eosinophilia-associated basal plasmacytosis: an early and sensitive histologic feature of inflammatory bowel disease. APMIS 125:179\u2013183","journal-title":"APMIS"},{"key":"1896_CR4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1023\/A:1010659803912","volume":"46","author":"M Lampinen","year":"2001","unstructured":"Lampinen M, Carlson M, Sangfelt P, Taha Y, Th\u00f6rn M, L\u00f6\u00f6f L, Raab Y, Venge P (2001) IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci 46:2004\u20132009","journal-title":"Dig Dis Sci"},{"key":"1896_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/ecco-jcc\/jjv097","volume":"9","author":"C Flores","year":"2015","unstructured":"Flores C, Francesconi CF, Meurer L (2015) Quantitative assessment of CD30 + lymphocytes and eosinophils for the histopathological differential diagnosis of inflammatory bowel disease. J Crohns Colitis 9:763\u2013768","journal-title":"J Crohns Colitis"},{"key":"1896_CR6","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1111\/j.1572-0241.1999.01223.x","volume":"94","author":"M Carlson","year":"1999","unstructured":"Carlson M, Raab Y, Peterson C, H\u00e4llgren R, Venge P (1999) Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol 94:1876\u20131883","journal-title":"Am J Gastroenterol"},{"key":"1896_CR7","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1111\/j.1572-0241.1999.01640.x","volume":"94","author":"O Saitoh","year":"1999","unstructured":"Saitoh O, Kojima K, Sugi K, Matsuse R, Uchida K, Tabata K, Nakagawa K, Kayazawa M, Hirata I, Katsu K (1999) Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am J Gastroenterol 94:3513\u20133520","journal-title":"Am J Gastroenterol"},{"key":"1896_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1572-0241.2001.03743.x","volume":"96","author":"P Sangfelt","year":"2001","unstructured":"Sangfelt P, Carlson M, Th\u00f6rn M, L\u00f6\u00f6f L, Raab Y (2001) Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Am J Gastroenterol 96:1085\u20131090","journal-title":"Am J Gastroenterol"},{"key":"1896_CR9","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1136\/gut.2003.036418","volume":"53","author":"G Kristj\u00e1nsson","year":"2004","unstructured":"Kristj\u00e1nsson G, Venge P, Wanders A, L\u00f6\u00f6f L, H\u00e4llgren R (2004) Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 53:1806\u20131812","journal-title":"Gut"},{"key":"1896_CR10","doi-asserted-by":"publisher","first-page":"O420","DOI":"10.1111\/codi.12725","volume":"16","author":"P Zezos","year":"2014","unstructured":"Zezos P, Patsiaoura K, Nakos A, Mpoumponaris A, Vassiliadis T, Giouleme O, Pitiakoudis M, Kouklakis G, Evgenidis N (2014) Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy. Colorectal Dis 16:O420\u2013O430","journal-title":"Colorectal Dis"},{"key":"1896_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/1319-3767.80383","volume":"17","author":"S Azad","year":"2011","unstructured":"Azad S, Sood N, Sood A (2011) Biological and histological parameters as predictors of relapse in ulcerative colitis: a prospective study. Saudi J Gastroenterol 17:194\u2013198","journal-title":"Saudi J Gastroenterol"},{"key":"1896_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.dld.2016.11.007","volume":"49","author":"S Morgenstern","year":"2017","unstructured":"Morgenstern S, Brook E, Rinawi F, Shamir R, Assa A (2017) Tissue and peripheral eosinophilia as predictors for disease outcome in children with ulcerative colitis. Dig Liver Dis 49:170\u2013174","journal-title":"Dig Liver Dis"},{"key":"1896_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2036.2008.03913.x","volume":"29","author":"G Casella","year":"2009","unstructured":"Casella G, Villanacci V, Fisogni S, Cambareri AR, Di Bella C, Corazzi N, Gorla S, Baldini V, Bassotti G (2009) Colonic left-side increase of eosinophils: a clue to drug-related colitis in adults. Aliment Pharmacol Ther 29:535\u2013541","journal-title":"Aliment Pharmacol Ther"},{"key":"1896_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.dld.2010.12.016","volume":"43","author":"V Villanacci","year":"2011","unstructured":"Villanacci V, Casella G, Bassotti G (2011) The spectrum of drug-related colitides: important entities, though frequently overlooked. Dig Liver Dis 43:523\u2013528","journal-title":"Dig Liver Dis"},{"key":"1896_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317:1625\u20131629","journal-title":"N Engl J Med"},{"key":"1896_CR16","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462\u20132476","journal-title":"N Engl J Med"},{"key":"1896_CR17","first-page":"CD011450","volume":"1","author":"N Mohammed Vashist","year":"2018","unstructured":"Mohammed Vashist N, Samaan M, Mosli MH, Parker CE, MacDonald JK, Nelson SA, Zou GY, Feagan BG, Khanna R, Jairath V (2018) Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev 1:CD011450","journal-title":"Cochrane Database Syst Rev"},{"key":"1896_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749\u2013753","journal-title":"Gut"},{"key":"1896_CR19","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1038\/s41598-017-07338-x","volume":"7","author":"V Villanacci","year":"2017","unstructured":"Villanacci V, Antonelli E, Lanzarotto F, Bozzola A, Cadei M, Bassotti G (2017) Usefulness of different pathological scores to assess healing of the mucosa in inflammatory bowel diseases: a real life study. Sci Rep 7:6839","journal-title":"Sci Rep"},{"key":"1896_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.crohns.2013.06.001","volume":"7","author":"F Magro","year":"2013","unstructured":"Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R, European Society of Pathology (ESP); European Crohn\u2019s and Colitis Organisation (ECCO) (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7:827\u2013851","journal-title":"J Crohns Colitis"},{"key":"1896_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/his.13228","volume":"71","author":"JR Conner","year":"2017","unstructured":"Conner JR, Kirsch R (2017) The pathology and causes of tissue eosinophilia in the gastrointestinal tract. Histopathology 71:177\u2013199","journal-title":"Histopathology"},{"key":"1896_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.dld.2017.01.161","volume":"49","author":"P Gionchetti","year":"2017","unstructured":"Gionchetti P, Rizzello F, Annese V, Armuzzi A, Biancone L, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D\u2019Inc\u00e0 R, Fries W, Kohn A, Orlando A, Papi C, Vecchi M, Ardizzone S, Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) (2017) Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease. Dig Liver Dis 49:604\u2013617","journal-title":"Dig Liver Dis"},{"key":"1896_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/biomet\/30.1-2.81","volume":"30","author":"M Kendall","year":"1938","unstructured":"Kendall M (1938) A new measure of rank correlation. Biometrika 30:81\u201389","journal-title":"Biometrika"},{"key":"1896_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 2:1041\u20131048","journal-title":"Br Med J"},{"key":"1896_CR25","doi-asserted-by":"publisher","first-page":"6628","DOI":"10.3748\/wjg.v23.i36.6628","volume":"23","author":"K Dubois-Camacho","year":"2017","unstructured":"Dubois-Camacho K, Ottum PA, Franco-Mu\u00f1oz D, De la Fuente M, Torres-Riquelme A, D\u00edaz-Jim\u00e9nez D, Olivares-Morales M, Astudillo G, Quera R, Hermoso MA (2017) Glucocorticosteroid therapy in inflammatory bowel diseases: from clinical practice to molecular biology. World J Gastroenterol 23:6628\u20136638","journal-title":"World J Gastroenterol"},{"key":"1896_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","volume":"53","author":"K Matsuoka","year":"2018","unstructured":"Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K, Kunisaki R, Motoya S, Nagahori M, Nakase H, Omata F, Saruta M, Watanabe T, Tanaka T, Kanai T, Noguchi Y, Takahashi KI, Watanabe K, Hibi T, Suzuki Y, Watanabe M, Sugano K, Shimosegawa T (2018) Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol 53:305\u2013353","journal-title":"J Gastroenterol"},{"key":"1896_CR27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/ajg.2011.70","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Bernstein CN, Khan KJ, Abreu MT, Marshall JK, Talley NJ, Moayyedi P (2011) Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 106:590\u2013599","journal-title":"Am J Gastroenterol"},{"key":"1896_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/gast.2001.26279","volume":"121","author":"WA Faubion Jr","year":"2001","unstructured":"Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ (2001) The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121:255\u2013260","journal-title":"Gastroenterology"},{"key":"1896_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4321\/S1130-01082004000800003","volume":"96","author":"M Abu-Suboh Abadia","year":"2004","unstructured":"Abu-Suboh Abadia M, Casellas F, Vilaseca J, Malagelada JR (2004) Response of first attack of inflammatory bowel disease requiring hospital admission to steroid therapy. Rev Esp Enferm Dig 96:539\u2013547","journal-title":"Rev Esp Enferm Dig"},{"key":"1896_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2036.2006.02974.x","volume":"24","author":"GT Ho","year":"2006","unstructured":"Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J (2006) The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 24:319\u2013330","journal-title":"Aliment Pharmacol Ther"},{"key":"1896_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/ibd.20843","volume":"15","author":"D Bojic","year":"2009","unstructured":"Bojic D, Radojicic Z, Nedeljkovic-Protic M, Al-Ali M, Jewell DP, Travis SP (2009) Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992\u20131993. Inflamm Bowel Dis 15:823\u2013828 cohort )","journal-title":"Inflamm Bowel Dis"},{"key":"1896_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10620-017-4450-0","volume":"62","author":"T Rai","year":"2017","unstructured":"Rai T, Choudhury BN, Kedia S, Bopanna S, Venigalla PM, Garg SK, Singla V, Makharia G, Ahuja V (2017) Short-Term Clinical response to corticosteroids can predict long-term natural history of ulcerative colitis: prospective study experience. Dig Dis Sci 62:1025\u20131034","journal-title":"Dig Dis Sci"},{"key":"1896_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2478\/v10039-012-0029-3","volume":"57","author":"O Stasikowska-Kanicka","year":"2012","unstructured":"Stasikowska-Kanicka O, Danilewicz M, G\u0142owacka A, W\u0105growska-Danilewicz M (2012) Mast cells and eosinophils are involved in activation of ulcerative colitis. Adv Med Sci 57:230\u2013236","journal-title":"Adv Med Sci"},{"key":"1896_CR34","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/gut.2005.066423","volume":"54","author":"M Lampinen","year":"2005","unstructured":"Lampinen M, R\u00f6nnblom A, Amin K, Kristjansson G, Rorsman F, Sangfelt P, S\u00e4fsten B, Wagner M, Wanders A, Winqvist O, Carlson M (2005) Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut 54:1714\u20131720","journal-title":"Gut"},{"key":"1896_CR35","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1136\/gut.2005.072595","volume":"54","author":"S Al-Haddad","year":"2005","unstructured":"Al-Haddad S, Riddel RH (2005) The role of eosinophils in inflammatory bowel disease. Gut 54:1674\u20131675","journal-title":"Gut"},{"key":"1896_CR36","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1053\/j.gastro.2011.01.042","volume":"140","author":"C Wallon","year":"2011","unstructured":"Wallon C, Persborn M, J\u00f6nsson M, Wang A, Phan V, Lampinen M, Vicario M, Santos J, Sherman PM, Carlson M, Ericson AC, McKay DM, S\u00f6derholm JD (2011) Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis. Gastroenterology 140:1597\u20131607","journal-title":"Gastroenterology"},{"key":"1896_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1189\/jlb.1212640","volume":"94","author":"M Lampinen","year":"2013","unstructured":"Lampinen M, Waddell A, Ahrens R, Carlson M, Hogan SP (2013) CD14+ CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis. J Leukoc Biol 94:1061\u20131070","journal-title":"J Leukoc Biol"},{"key":"1896_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1084\/jem.20081756","volume":"206","author":"Y Mori","year":"2009","unstructured":"Mori Y, Iwasaki H, Kohno K, Yoshimoto G, Kikushige Y, Okeda A, Uike N, Niiro H, Takenaka K, Nagafuji K, Miyamoto T, Harada M, Takatsu K, Akashi K (2009) Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor. J Exp Med 206:183\u2013193","journal-title":"J Exp Med"},{"key":"1896_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.iac.2007.07.004","volume":"27","author":"SJ Ackerman","year":"2007","unstructured":"Ackerman SJ, Bochner BS (2007) Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol Allergy Clin N Am 27:357\u2013375","journal-title":"Immunol Allergy Clin N Am"},{"key":"1896_CR40","doi-asserted-by":"publisher","first-page":"147174","DOI":"10.1146\/annurev.immunol.24.021605.090720","volume":"24","author":"ME Rothenberg","year":"2006","unstructured":"Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24:147174","journal-title":"Annu Rev Immunol"},{"key":"1896_CR41","doi-asserted-by":"publisher","first-page":"e82300","DOI":"10.1371\/journal.pone.0082300","volume":"8","author":"LA Coburn","year":"2013","unstructured":"Coburn LA, Horst SN, Chaturvedi R, Brown CT, Allaman MM, Scull BP, Singh K, Piazuelo MB, Chitnavis MV, Hodges ME, Rosen MJ, Williams CS, Slaughter JC, Beaulieu DB, Schwartz DA, Wilson KT (2013) High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis. PLoS One 8:e82300","journal-title":"PLoS One"},{"key":"1896_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bpg.2005.01.009","volume":"19","author":"S Khan","year":"2005","unstructured":"Khan S (2005) Eosinophilic gastroenteritis. Best Pract Res Clin Gastroenterol 19:177\u2013198","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1896_CR43","first-page":"39","volume":"7","author":"M Iborra","year":"2014","unstructured":"Iborra M, Alvarez-Sotomayor D, Nos P (2014) Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis. Clin Exp Gastroenterol 7:39\u201346","journal-title":"Clin Exp Gastroenterol"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10151-018-1896-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-018-1896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-018-1896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:21:01Z","timestamp":1575937261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10151-018-1896-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1007\/s10151-018-1896-9","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declares that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Since this was a retrospective study, no patient identification was needed, clinical and pathologic data were completely anonymized and no study-driven clinical intervention was performed. Therefore, our Institutional Review Board waived formal review and approval, deeming the study to be an extension of the existing procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}